Accumulating evidence has indicated that JAK2/STAT3 pathway is a key mediator of cardiac hypertrophy.9 Deactivating JAK2 attenuates the cardiac dysfunction in mice after MI or ischaemia/reperfusion injury. Here, JAK2 is linked to cardiac hypertrophy.